On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Asociacion Centro de Investigacion Cooperativa en Biociencias's own share of each project, not the project's full budget.
- Horizon Europe€12.8M · 30 projects
- Horizon 2020€12.5M · 22 projects
- FP7 (2007 to 2013)€2.6M · 6 projects
Projects
58 EU-funded projects, newest first. Asociacion Centro de Investigacion Cooperativa en Biociencias led 30 of them as coordinator. Each links to the official record.
- GLYCODECD44Coordinator
Unravelling Glycosylation Codes in Cancer at the Molecular Level: An Interdisciplinary Approach for the Dissection of the Recognition Features of CD44 by Galectins and Selectins
Horizon Europe · 2027–2029 · Project on CORDIS ↗
€194ktheir share - GlycoScopeCoordinator
Glycoproteins with homogeneous glycosylation to define unexplored lectin binding properties
Horizon Europe · 2027–2029 · Project on CORDIS ↗
€194ktheir share - ProofReadingCoordinator
European doctoral network for proofreading the proteome
Horizon Europe · 2027–2030 · Project on CORDIS ↗
€564ktheir share - GlyCaBiotaPartner
Doctoral Training Network on Glycan–Cancer–Microbiota Interactions for Therapeutic and Diagnostic Innovation in Colorectal cancer
Horizon Europe · 2027–2030 · Project on CORDIS ↗
€282ktheir share - VaccinNateCoordinator
From adjuvants-based vaccines for inflammatory diseases to refined vaccine adjuvants
Horizon Europe · 2026–2028 · Project on CORDIS ↗
€194ktheir share - RGNcestryPartner
Tracing and harnessing the ancestry of RNA-guided nucleases
Horizon Europe · 2026–2032 · Project on CORDIS ↗
€2.4Mtheir share - EVADEREPartner
Enhanced VAccines DEsign against antimicrobial REsistance
Horizon Europe · 2026–2029 · Project on CORDIS ↗
€282ktheir share - UnMissCoordinator
Uncovering the hidden origin behind the missing heritability
Horizon Europe · 2025–2030 · Project on CORDIS ↗
€2.0Mtheir share - IMMUFELLOWAssociated partner
Interdisciplinary and Intersectoral Research Fellowship Program for Future Leaders in Immunology
Horizon Europe · 2025–2030 · Project on CORDIS ↗
- BiParatopicCoordinator
Bispecific bi-paratopic antibodies for the treatment of cancer
Horizon Europe · 2025–2026 · Project on CORDIS ↗
€150ktheir share - InFlaMePartner
Counter-acting the pandemic potential of flaviviruses: addressing virus-host interactions and defense strategies to design new therapeutics against WNV and DENV
Horizon Europe · 2025–2028 · Project on CORDIS ↗
€625ktheir share - CARAMELPartner
CArdiovascular Risk Assessment in MEnopausaL women via multimodal data analysis enabling personalized prevention strategies
Horizon Europe · 2024–2029 · Project on CORDIS ↗
€816ktheir share - ADJUPROBECoordinator
LEAD ADJUVANT PROBE AS A DUAL TECHNOLOGICAL TOOL TO ADVANCE NEXT-GENERATION VACCINE DEVELOPMENT
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€150ktheir share - MagFetProgCoordinator
Magnesium and fetal metabolic programming: an approach to preventing a life-cycle of metabolic diseases
Horizon Europe · 2024–2027 · Project on CORDIS ↗
€194ktheir share - EPIMemoryCoordinator
Epithelial Memory to Candida albicans during commensalism and infection
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€165ktheir share - SPIRALCoordinator
Structural exploration of GD3 ganglioside-COVID spike Protein Interaction and siglec-7 Role in inhibition of virAL infection
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€169ktheir share - ADJU-PLATFORMCoordinator
MINIMAL SAPONIN-BASED ADJUVANT VACCINE PLATFORM
Horizon Europe · 2024–2025 · Project on CORDIS ↗
€150ktheir share - ENSCCPartner
European Network on the Supramolecular Chemistry of Carbohydrates
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€252ktheir share - GLYCO-NPartner
GLYCOprotein N-glycosylation from non-life to eukaryotes: a Doctoral Network to expand the knowledge on a ubiquitous posttranslational modification of proteins
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€252ktheir share - PLIADESPartner
AI-Enabled Data Lifecycles Optimization and Data Spaces Integration for Increased Efficiency and Interoperability
Horizon Europe · 2024–2027 · Project on CORDIS ↗
€203ktheir share - Glyco13CellCoordinator
Isotopically labelling of cell surface glycans to illuminate infectious processes at atomic resolution
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€1.5Mtheir share - CARESCoordinator
Human ECM-based platform for anti-cancer drug testing - CARES (CAncer dRug tESting)
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€51ktheir share - ADJUVACCINECoordinator
Development of a marketable adjuvant candidate for vaccine applications
Horizon Europe · 2023–2024 · Project on CORDIS ↗
€150ktheir share - CoDietPartner
COMBATTING DIET RELATED NON-COMMUNICABLE DISEASE THROUGH ENHANCED SURVEILLANCE
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€406ktheir share - GLYCOTwinningPartner
GLYCOTwinning: Building Networks to Excel in Glycosciences
Horizon Europe · 2022–2025 · Project on CORDIS ↗
€234ktheir share - halt-RONINPartner
Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€535ktheir share - EVCAPartner
Centre for Excellence in Diagnostic and Advanced Therapeutics based on Extracellular Vesicles
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€208ktheir share - R-NMRPartner
Remote NMR (R-NMR): Moving NMR infrastructures to remote access capabilities
Horizon Europe · 2022–2025 · Project on CORDIS ↗
€50ktheir share - SPIDVACPartner
Improved control of priority animal diseases: Novel vaccines and companion diagnostic tests for African horse sickness, peste des petits ruminants and foot-and-mouth disease
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€294ktheir share - FIH-IOCoordinator
Development of a first-in-class inhibitor of FIH for cancer immunotherapy
Horizon Europe · 2022–2023 · Project on CORDIS ↗
€150ktheir share - CD28Coordinator
Probing CD28 as checkpoint for T cell co-stimulation in cancer and infection
Horizon 2020 · 2021–2024 · Project on CORDIS ↗
€246ktheir share - PIPgenPartner
PI3K/PTEN-related monogenic disease to understand cancer
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€251ktheir share - BioUPGRADEPartner
Biocatalytic upgrading of natural biopolymers for reassembly as multipurpose materials
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€501ktheir share - GLYTUNESPartner
A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€251ktheir share - MyeRIBOPartner
Deconstructing the Translational Control of Myelination by Specialized Ribosomes
Horizon 2020 · 2020–2026 · Project on CORDIS ↗
€14ktheir share - QS21-MechCoordinator
Target identification and elucidation of the molecular mechanism of action of saponin vaccine adjuvants QS-21 (QS21Mech)
Horizon 2020 · 2020–2022 · Project on CORDIS ↗
€173ktheir share - CancerADAPTCoordinator
Targeting the adaptive capacity of prostate cancer through the manipulation of transcriptional and metabolic traits
Horizon 2020 · 2019–2025 · Project on CORDIS ↗
€2.0Mtheir share - proEVLifeCyclePartner
The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€251ktheir share - BactiVaxPartner
anti-Bacterial Innovative Vaccine Training Network.
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€502ktheir share - GlycoMabsCoordinator
Chemoenzymatic glyco-engineering of therapeutic monoclonal antibodies
Horizon 2020 · 2019–2021 · Project on CORDIS ↗
€161ktheir share
Show 18 more projects
- NextGen IOCoordinator
Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€2.0Mtheir share - RECGLYCANMRCoordinator
Breaking the limits in glycan recognition by NMR
Horizon 2020 · 2018–2024 · Project on CORDIS ↗
€2.5Mtheir share - UbiCODEPartner
European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets
Horizon 2020 · 2018–2022 · Project on CORDIS ↗
€248ktheir share - LITMUSPartner
Liver Investigation: Testing Marker Utility in Steatohepatitis
Horizon 2020 · 2017–2024 · Project on CORDIS ↗
€403ktheir share - MetaboMARKERCoordinator
A metabolism-based prognostic biomarker for prostate cancer
Horizon 2020 · 2017–2018 · Project on CORDIS ↗
€150ktheir share - ADJUV-ANT VACCINESCoordinator
Elucidating the Molecular Mechanisms of Synthetic Saponin Adjuvants and Development of Novel Self-Adjuvanting Vaccines
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€1.5Mtheir share - €297ktheir share
- FCSSSLPCoordinator
First Chemoselective Synthesis and Structural Studies of Lasso Peptides
Horizon 2020 · 2016–2019 · Project on CORDIS ↗
€257ktheir share - GLYCOVAXPartner
A training network for the rational design of the next generation of well-defined glycoconjugate vaccines
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
€248ktheir share - SchmaVirusVacDiagCoordinator
Novel vaccine and diagnostic strategies against Schmallenberg virus
Horizon 2020 · 2015–2017 · Project on CORDIS ↗
€158ktheir share - ACMCoordinator
Cholesterol metabolism as a driver of prostate cancer aggressiveness
Horizon 2020 · 2015–2017 · Project on CORDIS ↗
€158ktheir share - TOLLerantPartner
Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.
Horizon 2020 · 2015–2018 · Project on CORDIS ↗
€248ktheir share - THE NASCENT CODECoordinator
Unravelling the Nascent Code: Signals sensed and transmitted by the nascent chain to acquire its functional state or reprogram gene expression
FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗
€100ktheir share - ANTIDOTEPartner
Anti-tick Vaccines to Prevent Tick-borne Diseases in Europe
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€373ktheir share - CANCERMETABCoordinator
Metabolic requirements for prostate cancer cell fitness
FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗
€1.5Mtheir share - PTENLKB1Coordinator
Implication of energy sensing pathways in prostate cancer biology
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€100ktheir share - UPSTREAMCoordinator
European Research Training in the Ubiquitin Proteasome System
FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗
€256ktheir share - NANOTHERPartner
Integration of Novel Nanoparticle based Technology for Therapeutics and Diagnosis of different types of Cancer
FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗
€288ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Centre National de la Recherche Scientifique CNRSFrance · 10 shared projects
- Imperial College of Science Technology and MedicineUnited Kingdom · 6 shared projects
- Universidade Nova de LisboaPortugal · 5 shared projects
- Universidad del Pais Vasco/ Euskal Herriko UnibertsitateaSpain · 5 shared projects
- Kobenhavns UniversitetDenmark · 4 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 4 shared projects
- Consiglio Nazionale Delle RicercheItaly · 4 shared projects
- Ludwig-Maximilians-Universitaet MuenchenGermany · 4 shared projects
- Academisch Ziekenhuis LeidenNetherlands · 4 shared projects
- Universitat de BarcelonaSpain · 4 shared projects
- Johann Wolfgang Goethe-Universitaet Frankfurt am MainGermany · 4 shared projects
- Universita Degli Studi di Napoli Federico IiItaly · 4 shared projects
- Universita Degli Studi di FirenzeItaly · 4 shared projects
- Atlas Molecular Pharma SLSpain · 4 shared projects
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften eVGermany · 3 shared projects
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 3 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- agriculture
- alkaline earth metals
- allergology
- amorphous semiconductors
- animal husbandry
- antibiotic resistance
- antibiotics
- antivirals
- artificial intelligence
- asthma
- bacteriology
- biochemistry
- biological interactions
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
